For example, by utilizing both biomarkers such ascTnI in combination with myoglobin could improve the diagnostic accuracyfor a second heart attack, even though myoglobin lacks specificityas a CVD marker and has a short half-life of 10–20 min.21,22. This evidence concerns the gene MB and myocardial infarction.